UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1901) 1901
Book Chapter (9) 9
Dissertation (6) 6
Magazine Article (3) 3
Newspaper Article (3) 3
Government Document (2) 2
Book / eBook (1) 1
Conference Proceeding (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (1309) 1309
life sciences & biomedicine (1245) 1245
humans (1029) 1029
animals (948) 948
male (933) 933
female (623) 623
oximes (570) 570
biological and medical sciences (567) 567
medical sciences (546) 546
oximes - pharmacology (483) 483
oximes - administration & dosage (454) 454
rats (418) 418
pharmacology & pharmacy (388) 388
toxicology (361) 361
adult (321) 321
oximes - therapeutic use (319) 319
middle aged (313) 313
mice (290) 290
aged (218) 218
pharmacology. drug treatments (204) 204
melanoma - drug therapy (198) 198
imidazoles - administration & dosage (187) 187
oximes - chemistry (181) 181
technetium tc 99m exametazime (176) 176
acetylcholinesterase (170) 170
dose-response relationship, drug (164) 164
oxime (161) 161
proto-oncogene proteins b-raf - genetics (160) 160
oximes - pharmacokinetics (157) 157
melanoma (153) 153
oximes - adverse effects (152) 152
oncology (151) 151
rats, wistar (150) 150
chemistry (145) 145
acetylcholinesterase - metabolism (140) 140
proto-oncogene proteins b-raf - antagonists & inhibitors (140) 140
neurosciences & neurology (139) 139
biochemistry & molecular biology (138) 138
physical sciences (137) 137
analysis (135) 135
mutation (133) 133
treatment outcome (131) 131
time factors (130) 130
pyrimidinones - administration & dosage (128) 128
cholinesterase reactivators - pharmacology (127) 127
pyridones - administration & dosage (127) 127
organotechnetium compounds (126) 126
poisoning (122) 122
neurosciences (120) 120
tomography, emission-computed, single-photon (116) 116
pyridinium compounds - pharmacology (114) 114
skin neoplasms - drug therapy (111) 111
administration, oral (106) 106
atropine (103) 103
melanoma - genetics (101) 101
chemical and industrial products toxicology. toxic occupational diseases (100) 100
rats, sprague-dawley (99) 99
abridged index medicus (97) 97
antidotes - therapeutic use (96) 96
research (95) 95
antineoplastic combined chemotherapy protocols - therapeutic use (94) 94
organophosphate poisoning (94) 94
adolescent (88) 88
brain - diagnostic imaging (88) 88
cholinesterase inhibitors - toxicity (87) 87
dogs (87) 87
imidazoles - adverse effects (87) 87
dermatology (86) 86
brain - drug effects (83) 83
brain - metabolism (83) 83
cholinesterase reactivators - therapeutic use (83) 83
melanoma - pathology (83) 83
drug therapy, combination (81) 81
imidazoles - therapeutic use (81) 81
neurology (81) 81
oximes - metabolism (81) 81
brain (80) 80
lethal dose 50 (80) 80
care and treatment (79) 79
pyridinium compounds - therapeutic use (78) 78
radiology, nuclear medicine & medical imaging (78) 78
dabrafenib (77) 77
pharmacokinetics (77) 77
structure-activity relationship (77) 77
cholinesterase reactivators - administration & dosage (75) 75
nerve agents (75) 75
pyridinium compounds - administration & dosage (75) 75
health aspects (73) 73
molecular structure (73) 73
organophosphorus compounds (73) 73
atropine - therapeutic use (72) 72
indoles - pharmacology (72) 72
organophosphates (72) 72
toxicity (72) 72
nerve gas (71) 71
atropine - pharmacology (70) 70
chemistry, medicinal (70) 70
enzymes (70) 70
hi-6 (70) 70
skin neoplasms - pathology (70) 70
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1863) 1863
Japanese (26) 26
German (11) 11
Czech (10) 10
French (10) 10
Russian (10) 10
Polish (6) 6
Spanish (5) 5
Croatian (4) 4
Serbian (4) 4
Italian (3) 3
Portuguese (3) 3
Hebrew (2) 2
Bulgarian (1) 1
Chinese (1) 1
Danish (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The lancet oncology, ISSN 1470-2045, 2015, Volume 16, Issue 13, pp. 1389 - 1398
Hematology, Oncology and Palliative Medicine | Life Sciences & Biomedicine | Oncology | Science & Technology | Prospective Studies | Skin Neoplasms - drug therapy | Oximes - adverse effects | Humans | Oximes - administration & dosage | Protein Kinase Inhibitors - adverse effects | Indoles - administration & dosage | Time Factors | DNA Mutational Analysis | Imidazoles - therapeutic use | MAP Kinase Kinase Kinases - antagonists & inhibitors | Genetic Predisposition to Disease | Administration, Oral | Imidazoles - adverse effects | Pyrimidinones - adverse effects | Pyrimidinones - therapeutic use | Risk Factors | MAP Kinase Kinase Kinases - metabolism | Disease Progression | Proto-Oncogene Proteins B-raf - antagonists & inhibitors | Protein Kinase Inhibitors - administration & dosage | Phenotype | Indoles - adverse effects | Intention to Treat Analysis | Quality of Life | Indoles - therapeutic use | Biomarkers, Tumor - genetics | Pyrimidinones - administration & dosage | Mutation | Sulfonamides - administration & dosage | Melanoma - mortality | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Imidazoles - administration & dosage | Oximes - therapeutic use | Pyridones - administration & dosage | Melanoma - genetics | Skin Neoplasms - mortality | Surveys and Questionnaires | Skin Neoplasms - pathology | Drug Administration Schedule | Treatment Outcome | Melanoma - secondary | Disease-Free Survival | Sulfonamides - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Protein Kinase Inhibitors - therapeutic use | Proto-Oncogene Proteins B-raf - genetics | Melanoma - drug therapy | Skin Neoplasms - genetics | Sulfonamides - adverse effects | Pyridones - therapeutic use | Pyridones - adverse effects | Care and treatment | Hospitals | Metastasis | Gene mutations | Comparative analysis | Index Medicus
Journal Article
Nature medicine, ISSN 1078-8956, 09/2019, Volume 25, Issue 9, pp. 1422 - 1427
Journal Article
Annals of oncology, ISSN 0923-7534, 07/2017, Volume 28, Issue 7, pp. 1631 - 1639
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2012, Volume 379, Issue 9829, pp. 1893 - 1901
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Tumors of the skin and soft tissue. Premalignant lesions | Neurology | General aspects | Tumors of the nervous system. Phacomatoses | Dermatology | Biological and medical sciences | Medical sciences | Oximes - adverse effects | Humans | Middle Aged | Carcinoma, Squamous Cell - chemically induced | Oximes - administration & dosage | Imidazoles - administration & dosage | Male | Fatigue - chemically induced | Antineoplastic Agents - administration & dosage | Fever - chemically induced | Indoles - administration & dosage | Brain Neoplasms - secondary | Neoplasms - genetics | Antineoplastic Agents - adverse effects | Melanoma - genetics | Adult | Female | Drug Administration Schedule | Imidazoles - adverse effects | Genotype | Treatment Outcome | Skin Neoplasms - chemically induced | Brain Neoplasms - drug therapy | Mutation - genetics | Melanoma - secondary | Neoplasms - drug therapy | Proto-Oncogene Proteins B-raf - antagonists & inhibitors | Maximum Tolerated Dose | Indoles - adverse effects | Proto-Oncogene Proteins B-raf - genetics | Melanoma - drug therapy | Sulfonamides - adverse effects | Sulfonamides - administration & dosage | Antimitotic agents | Complications and side effects | Melanoma | Dosage and administration | Metastasis | Antineoplastic agents | Drug therapy | Clinical trials | Medical research | Chemotherapy | Mutation | Toxicity | Tumors | Index Medicus | Abridged Index Medicus
Journal Article
The oncologist (Dayton, Ohio), ISSN 1083-7159, 07/2017, Volume 22, Issue 7, pp. 823 - 833
BRAF | Mitogen‐activated protein kinase signaling system | Drug‐related side effects and adverse reactions | Protein kinase inhibitors | Melanoma | Mitogen-activated protein kinase signaling system | Drug-related side effects and adverse reactions | Life Sciences & Biomedicine | Oncology | Science & Technology | Oximes - adverse effects | Humans | Fever - therapy | Oximes - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Imidazoles - administration & dosage | Carbamates - administration & dosage | Protein Kinase Inhibitors - adverse effects | Fever - chemically induced | Pyridones - administration & dosage | Benzimidazoles - administration & dosage | Antineoplastic Agents - adverse effects | Benzimidazoles - adverse effects | Skin Diseases - chemically induced | Piperidines - administration & dosage | Imidazoles - adverse effects | Pyrimidinones - adverse effects | Azetidines - adverse effects | Mitogen-Activated Protein Kinase Kinases - antagonists & inhibitors | Melanoma - pathology | Proto-Oncogene Proteins B-raf - antagonists & inhibitors | Vemurafenib | Azetidines - administration & dosage | Indoles - adverse effects | Proto-Oncogene Proteins B-raf - genetics | Melanoma - drug therapy | Piperidines - adverse effects | Sulfonamides - adverse effects | Carbamates - adverse effects | Pyrimidinones - administration & dosage | Pyridones - adverse effects | Sulfonamides - administration & dosage | Index Medicus | Melanoma and Cutaneous Malignancies
Journal Article
Journal Article
The New England journal of medicine, ISSN 0028-4793, 01/2015, Volume 372, Issue 1, pp. 30 - 39
Journal Article